Chronos Archive seal
The Human Record

Charlotte Brontë

Case HR-NI025 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
21 April 1816 – 31 March 1855
Synthetic DOB
1987-04-21
Index visit
2026-01-13 at age 38
Synthetic MRN
HR-NI025-SYN

Teaching objective: Prenatal care of a first pregnancy at 38 complicated by hyperemesis gravidarum, following ACOG Practice Bulletin 189 and RCOG Green-top Guideline 69 (2024): dating ultrasound; severity by the PUQE-24 score, weight, and hydration rather than urine ketones; electrolytes, magnesium, phosphate, liver tests, and thyroid tests with recognition of gestational transient thyrotoxicosis; stepwise antiemetics (doxylamine-pyridoxine, then metoclopramide, then ondansetron after counseling on the very small absolute risk of orofacial clefting); admission with intravenous saline and potassium, thiamine before any dextrose to prevent Wernicke encephalopathy, magnesium replacement, refeeding precautions, and weight-adjusted thromboprophylaxis; mental health screening with the PHQ-9 and EPDS; routine prenatal care at an advanced maternal age, with aneuploidy screening offered (cell-free DNA and nuchal translucency, with diagnostic testing available), low-dose aspirin for two moderate preeclampsia risk factors, and tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household. The historical cause of her death is disputed and is recorded as conflicting retrospective claims, not decided by the modern episode.

Historical timeline

DateEventClaims
21 April 1816Born in Thornton, Yorkshire.CLM-0001
15 September 1821Her mother dies after a long illness.CLM-0003, CLM-0004
1825Her elder sisters Maria and Elizabeth die.CLM-0005
1847Jane Eyre published under the name Currer Bell.CLM-0002
1848Her brother Branwell and her sister Emily die.CLM-0006, CLM-0007
28 May 1849Her sister Anne dies of tuberculosis.CLM-0007
29 June 1854Marries at Haworth.CLM-0008
November 1854Lingering cold and sore throat after a walk in the rain.CLM-0009
January 1855Onset of perpetual nausea and faintness.CLM-0010
15 February 1855Writes that she has been confined to bed for three weeks; the household servant dies about this time.CLM-0011, CLM-0012, CLM-0015
Third week of March 1855Low wandering delirium; she asks for food.CLM-0013, CLM-0017
31 March 1855Dies at Haworth; the death certificate gives phthisis, and other causes are proposed later.CLM-0013, CLM-0014, CLM-0016, CLM-0018, CLM-0019, CLM-0020

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Charlotte Brontë was born on 21 April 1816 in Thornton, Yorkshire, the third of six children of Maria Branwell and her husband, an Anglican clergyman. confirmed Charlotte Brontë supports
D Jane Eyre was first published in 1847 under the pseudonym Currer Bell. confirmed Charlotte Brontë supports
D Her mother died on 15 September 1821, in the 39th year of her age, after a long and painful illness. confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports
Charlotte Brontë supports
R Her mother's illness may have been cancer; one reference work says uterine cancer. The cause is a later interpretation.
Recorded as possible only.
possible Charlotte Brontë supports
Brontë family supports
D Her two elder sisters, Maria and Elizabeth, fell ill at the Clergy Daughters' School at Cowan Bridge and died at home in 1825, Maria on 6 May aged 11 and Elizabeth on 15 June aged 10; reference works give tuberculosis.
The causes are as given by the reference works; the school also had an outbreak of typhus.
probable Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports
Charlotte Brontë supports
Brontë family supports
D Her brother Branwell died on 24 September 1848, aged 31, of several conditions made worse by heavy drinking; tuberculosis is listed among them.
Family history only.
probable Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports
Charlotte Brontë supports
Brontë family supports
D Her sisters Emily and Anne died of tuberculosis, Emily on 19 December 1848 aged 30 and Anne on 28 May 1849 aged 29.
Household tuberculosis deaths; the reason for tuberculosis screening in the synthetic episode.
confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports
Charlotte Brontë supports
D On 29 June 1854 she married Arthur Bell Nicholls, her father's curate, at Haworth. confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
Charlotte Brontë supports
D In late November 1854, after a long walk on the moors to a waterfall that ended in heavy rain, she began to shiver and had a bad lingering sore throat and cold that made her thin and weak.
An intercurrent illness before the final one, in Gaskell's account.
confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
D Early in 1855, after a visit to Gawthorpe and a long walk over damp ground in thin shoes, she was attacked by "new sensations of perpetual nausea, and ever-recurring faintness"; a doctor who was called assigned a natural cause for her indisposition.
The onset of the final illness, in Gaskell's account.
confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
D The sickness increased until the very sight of food caused nausea. On 15 February 1855 she wrote that she had been confined to bed for three weeks, that up to then she had had excellent health since her marriage, and that she was much reduced and very weak. confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
D Tabitha Ackroyd, the family's elderly servant, died during Charlotte's illness; a literary historian writes that she died of a digestive infection six weeks before Charlotte.
Context for the infectious explanations in CLM-0018.
probable Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
Gezari J. The death of Charlotte Brontë supports
D About the third week of March 1855 a low wandering delirium came on, in which she begged constantly for food; she died early on Saturday 31 March 1855 at Haworth, in the 39th year of her age.
Record the death as a fact without detail.
confirmed Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports
Charlotte Brontë supports
D Her death certificate gave the cause of death as phthisis, a term for pulmonary tuberculosis. confirmed Charlotte Brontë supports
Gezari J. The death of Charlotte Brontë supports
Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports
D She is widely reported to have been in the early stages of pregnancy when she died; Gaskell records that her servant cheered her with the thought of the baby that was coming, and a letter of hers suggests that she was pregnant. The death certificate does not mention pregnancy.
The anchor for the synthetic first pregnancy.
probable Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports
Charlotte Brontë supports
Gezari J. The death of Charlotte Brontë supports
R Hyperemesis gravidarum has been proposed as the cause of her final illness and death.
Retrospective diagnosis; the synthetic episode teaches its modern management without asserting it as her diagnosis.
possible Charlotte Brontë supports
Brontë family supports
Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports
Gezari J. The death of Charlotte Brontë context
R A 2019 clinical nutrition paper agrees that hyperemesis gravidarum is the most likely diagnosis and suggests that the refeeding syndrome, after her appetite returned in the third week of March, caused her death; it argues there is no more than circumstantial evidence for tuberculosis and that Addison's disease fits poorly.
Retrospective interpretation; abstract read.
possible Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports
R A bacterial infection such as typhoid has also been suggested, possibly caught from the servant who died weeks earlier.
Retrospective interpretation.
possible Gezari J. The death of Charlotte Brontë supports
Brontë family supports
R A 1991 obstetrics paper doubts that she was ever pregnant and argues that tuberculosis with secondary Addison disease explains her terminal illness.
Retrospective interpretation; abstract read.
disputed Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 supports
R Tuberculosis as the cause of her death, as the death certificate records, is disputed; the diagnosis was made without modern tests, and later writers have proposed hyperemesis gravidarum, refeeding syndrome, typhoid, and Addison disease instead.
The diagnostic conflict is recorded, not resolved.
disputed Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports
Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 supports
Charlotte Brontë context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day active confirmed active CLM-0015, CLM-0016
S Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum resolved confirmed active CLM-0010, CLM-0011, CLM-0016, CLM-0017
S Hyperemesis gravidarum with metabolic disturbance: unable to keep fluids down, 7.4 percent weight loss, dehydration, hypokalemia, hyponatremia, hypochloremic alkalosis, low magnesium, and raised transaminases; PUQE-24 score 14 active confirmed both_with_link CLM-0010, CLM-0011, CLM-0016, CLM-0017
S Gestational transient thyrotoxicosis: suppressed TSH and mildly raised free T4 with hyperemesis, no goiter, eye signs, or tremor; no treatment needed resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-01-13 Hemoglobin [Mass/volume] in Blood 12.8 g/dL
Reference 11-15.5 g/dL
http://loinc.org · 718-7
S 2026-01-13 Leukocytes [#/volume] in Blood by Automated count 8.4 10*3/uL
Reference 4-13 10*3/uL
http://loinc.org · 6690-2
S 2026-01-13 Platelets [#/volume] in Blood by Automated count 248 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-01-13 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-01-13 Potassium [Moles/volume] in Serum or Plasma 3.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-01-13 Chloride [Moles/volume] in Serum or Plasma 102 mmol/L
Reference 98-107 mmol/L
http://loinc.org · 2075-0
S 2026-01-13 Carbon dioxide, total [Moles/volume] in Serum or Plasma 24 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-01-13 Urea nitrogen [Mass/volume] in Serum or Plasma 8 mg/dL
Reference 6-20 mg/dL
http://loinc.org · 3094-0
S 2026-01-13 Creatinine [Mass/volume] in Serum or Plasma 0.52 mg/dL
Reference 0.4-0.9 mg/dL
http://loinc.org · 2160-0
S 2026-01-13 Glucose [Mass/volume] in Serum or Plasma 76 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-01-13 Ketones [Mass/volume] in Urine by Test strip 15 mg/dL (high)
Reference <=0 mg/dL
http://loinc.org · 5797-6
S 2026-01-13 Fetal Crown Rump length US 11 mm
Reference Consistent with 7 weeks 1 day by the last menstrual period
http://loinc.org · 11957-8
S 2026-01-13 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 2026-01-20 Sodium [Moles/volume] in Serum or Plasma 136 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-01-20 Potassium [Moles/volume] in Serum or Plasma 3.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-01-20 Chloride [Moles/volume] in Serum or Plasma 99 mmol/L
Reference 98-107 mmol/L
http://loinc.org · 2075-0
S 2026-01-20 Carbon dioxide, total [Moles/volume] in Serum or Plasma 26 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-01-20 Urea nitrogen [Mass/volume] in Serum or Plasma 11 mg/dL
Reference 6-20 mg/dL
http://loinc.org · 3094-0
S 2026-01-20 Creatinine [Mass/volume] in Serum or Plasma 0.58 mg/dL
Reference 0.4-0.9 mg/dL
http://loinc.org · 2160-0
S 2026-01-20 Glucose [Mass/volume] in Serum or Plasma 74 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-01-20 Ketones [Mass/volume] in Urine by Test strip 40 mg/dL (high)
Reference <=0 mg/dL
http://loinc.org · 5797-6
S 2026-01-29 Hemoglobin [Mass/volume] in Blood 14.1 g/dL
Reference 11-15.5 g/dL
http://loinc.org · 718-7
S 2026-01-29 Sodium [Moles/volume] in Serum or Plasma 133 mmol/L (low)
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-01-29 Potassium [Moles/volume] in Serum or Plasma 3.1 mmol/L (low)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-01-29 Chloride [Moles/volume] in Serum or Plasma 94 mmol/L (low)
Reference 98-107 mmol/L
http://loinc.org · 2075-0
S 2026-01-29 Carbon dioxide, total [Moles/volume] in Serum or Plasma 31 mmol/L (high)
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-01-29 Urea nitrogen [Mass/volume] in Serum or Plasma 21 mg/dL (high)
Reference 6-20 mg/dL
http://loinc.org · 3094-0
S 2026-01-29 Creatinine [Mass/volume] in Serum or Plasma 0.71 mg/dL
Reference 0.4-0.9 mg/dL
http://loinc.org · 2160-0
S 2026-01-29 Glucose [Mass/volume] in Serum or Plasma 68 mg/dL (low)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-01-29 Magnesium [Mass/volume] in Serum or Plasma 1.6 mg/dL (low)
Reference 1.7-2.2 mg/dL
http://loinc.org · 19123-9
S 2026-01-29 Phosphate [Mass/volume] in Serum or Plasma 2.6 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 2026-01-29 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 66 U/L (high)
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-01-29 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 49 U/L (high)
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-01-29 Thyrotropin [Units/volume] in Serum or Plasma 0.03 mIU/L (low)
Reference 0.1-2.5 mIU/L
http://loinc.org · 3016-3
S 2026-01-29 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 2.1 ng/dL (high)
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-01-29 Ketones [Mass/volume] in Urine by Test strip 80 mg/dL (high)
Reference <=0 mg/dL
http://loinc.org · 5797-6
S 2026-02-10 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-02-10 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-02-10 Chloride [Moles/volume] in Serum or Plasma 101 mmol/L
Reference 98-107 mmol/L
http://loinc.org · 2075-0
S 2026-02-10 Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-02-10 Urea nitrogen [Mass/volume] in Serum or Plasma 9 mg/dL
Reference 6-20 mg/dL
http://loinc.org · 3094-0
S 2026-02-10 Creatinine [Mass/volume] in Serum or Plasma 0.55 mg/dL
Reference 0.4-0.9 mg/dL
http://loinc.org · 2160-0
S 2026-02-10 Glucose [Mass/volume] in Serum or Plasma 82 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-02-10 Magnesium [Mass/volume] in Serum or Plasma 1.9 mg/dL
Reference 1.7-2.2 mg/dL
http://loinc.org · 19123-9
S 2026-02-10 Phosphate [Mass/volume] in Serum or Plasma 3.4 mg/dL
Reference 2.5-4.5 mg/dL
http://loinc.org · 2777-1
S 2026-02-10 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-02-10 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 2026-02-10 Total score [EPDS] 9 http://loinc.org · 99046-5
S 2026-02-24 Fetal Crown Rump length US 70 mm
Reference Consistent with 13 weeks 1 day by the dating scan
http://loinc.org · 11957-8
S 2026-02-24 Fetal nuchal translucency measured by US 1.5 mm
Reference <=3.5 mm
http://loinc.org · 33069-6
S 2026-03-24 Hemoglobin [Mass/volume] in Blood 11.6 g/dL
Reference 11-15.5 g/dL
http://loinc.org · 718-7
S 2026-03-24 Thyrotropin [Units/volume] in Serum or Plasma 0.92 mIU/L
Reference 0.2-3 mIU/L
http://loinc.org · 3016-3
S 2026-03-24 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.1 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-03-24 Total score [EPDS] 5 http://loinc.org · 99046-5

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-01-13Body height152 cm8302-2S
2026-01-13Body weight45.1 kg29463-7S
2026-01-13Body mass index (BMI) [Ratio]19.5 kg/m239156-5S
2026-01-13Systolic blood pressure104 mm[Hg]8480-6S
2026-01-13Diastolic blood pressure66 mm[Hg]8462-4S
2026-01-13Heart rate84 /min8867-4S
2026-01-13Respiratory rate14 /min9279-1S
2026-01-13Body temperature36.7 Cel8310-5S
2026-01-13Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-01-20Body height152 cm8302-2S
2026-01-20Body weight44 kg29463-7S
2026-01-20Body mass index (BMI) [Ratio]19 kg/m239156-5S
2026-01-20Systolic blood pressure102 mm[Hg]8480-6S
2026-01-20Diastolic blood pressure64 mm[Hg]8462-4S
2026-01-20Heart rate92 /min8867-4S
2026-01-20Respiratory rate14 /min9279-1S
2026-01-20Body temperature36.8 Cel8310-5S
2026-01-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-01-29Body height152 cm8302-2S
2026-01-29Body weight42.6 kg29463-7S
2026-01-29Body mass index (BMI) [Ratio]18.4 kg/m239156-5S
2026-01-29Systolic blood pressure96 mm[Hg]8480-6S
2026-01-29Diastolic blood pressure60 mm[Hg]8462-4S
2026-01-29Heart rate108 /min8867-4S
2026-01-29Respiratory rate16 /min9279-1S
2026-01-29Body temperature36.9 Cel8310-5S
2026-01-29Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-02-10Body height152 cm8302-2S
2026-02-10Body weight43.6 kg29463-7S
2026-02-10Body mass index (BMI) [Ratio]18.9 kg/m239156-5S
2026-02-10Systolic blood pressure104 mm[Hg]8480-6S
2026-02-10Diastolic blood pressure64 mm[Hg]8462-4S
2026-02-10Heart rate86 /min8867-4S
2026-02-10Respiratory rate14 /min9279-1S
2026-02-10Body temperature36.7 Cel8310-5S
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-02-24Body height152 cm8302-2S
2026-02-24Body weight44.4 kg29463-7S
2026-02-24Body mass index (BMI) [Ratio]19.2 kg/m239156-5S
2026-02-24Systolic blood pressure106 mm[Hg]8480-6S
2026-02-24Diastolic blood pressure66 mm[Hg]8462-4S
2026-02-24Heart rate82 /min8867-4S
2026-02-24Respiratory rate14 /min9279-1S
2026-02-24Body temperature36.6 Cel8310-5S
2026-02-24Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-03-24Body height152 cm8302-2S
2026-03-24Body weight46.2 kg29463-7S
2026-03-24Body mass index (BMI) [Ratio]20 kg/m239156-5S
2026-03-24Systolic blood pressure108 mm[Hg]8480-6S
2026-03-24Diastolic blood pressure68 mm[Hg]8462-4S
2026-03-24Heart rate80 /min8867-4S
2026-03-24Respiratory rate14 /min9279-1S
2026-03-24Body temperature36.7 Cel8310-5S
2026-03-24Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Nausea and vomiting mild (PUQE-24 score 6 or less) and weight back to her pre-pregnancy 46.0 kg by about 17 weeks2026-03-24completedPUQE-24 score 4 and weight 46.2 kg at 17 weeks 1 day
Hydration and electrolytes normal within two weeks of any admission2026-02-10completedSodium, potassium, chloride, bicarbonate, magnesium, phosphate, and transaminases all normal nine days after discharge
An informed choice about aneuploidy screening and diagnostic testing by 13 weeks2026-02-24completedChose cell-free DNA screening (low risk) and the nuchal translucency scan (1.5 mm); declined diagnostic testing
Low-dose aspirin started between 12 and 16 weeks if indicated2026-02-24completedStarted at 13 weeks 1 day for two moderate risk factors
Tuberculosis screening completed and explained by the second visit2026-01-20completedInterferon-gamma release assay negative; no latent infection; no chest radiograph needed
Mood screened in each trimester, with support offered2026-03-24completedPHQ-9 5 at intake, EPDS 9 after the admission and 5 at 17 weeks; item 10 scored 0 each time

Interventions

InterventionStatusGuideline
First prenatal visit: dating ultrasound; blood count, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; metabolic panel and urinalysis because of vomiting; influenza vaccine; folic acid 0.4 mg daily in place of the iron-containing prenatal vitamin while nausea lastscompletedGL-USPSTF-AB, GL-CDC-PREGVAX
Nausea and vomiting, step by step: small frequent dry meals, fluids between meals, ginger if she wishes, and avoiding smells that trigger nausea; doxylamine-pyridoxine from today, raised to four tablets a day if needed; then a second drug (metoclopramide, promethazine, or ondansetron after counseling); PUQE-24 score, weight, pulse, blood pressure, and electrolytes at each visit; same-day review if she cannot keep fluids down for 24 hours or loses more than 5 percent of her pre-pregnancy weightcompletedGL-ACOG-NVP-2018, GL-RCOG-HG-2024
Maternal-fetal medicine consultation for a first pregnancy at 38 with moderate nausea and vomiting and early weight loss: escalation thresholds, aneuploidy screening and diagnostic options, preeclampsia prevention, tuberculosis risk, and the plan for the rest of the pregnancycompletedGL-ACOG-NVP-2018, GL-RCOG-HG-2024, GL-ACOG-ANEU-2020, GL-USPSTF-ASA-2021
Aneuploidy screening offered to all, with diagnostic testing available: cell-free DNA from 10 weeks, a nuchal translucency scan at 11 to 14 weeks, or chorionic villus sampling or amniocentesis; a detailed anatomy scan at 18 to 22 weekscompletedGL-ACOG-ANEU-2020
Tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household; a shielded chest radiograph and treatment decisions only if it is positivecompletedGL-USPSTF-LTBI-2023
Mental health: PHQ-9 at intake and the EPDS in each trimester and after any admission, with support for the strain of severe vomiting and for anxiety rooted in family losscompletedGL-ACOG-MH-2023, GL-USPSTF-PND-2019
Preeclampsia prevention: low-dose aspirin 81 mg at bedtime from 12 to 16 weeks until delivery if she has one high-risk or more than one moderate-risk factor (she has two: first pregnancy and age 35 or older); blood pressure at every visitcompletedGL-USPSTF-ASA-2021
Admission for hyperemesis gravidarum: 0.9% saline with potassium chloride guided by daily electrolytes; thiamine 100 mg intravenously before any dextrose, then orally; magnesium replacement; ondansetron after counseling and an electrocardiogram; stop metoclopramide; refeeding precautions with phosphate and magnesium checks as eating resumes; weight-adjusted enoxaparin while admitted; discharge when she keeps fluids and food downcompletedGL-ACOG-NVP-2018, GL-RCOG-HG-2024, GL-RCOG-VTE-2015
Thyroid: suppressed TSH with a mildly raised free T4 during hyperemesis is gestational transient thyrotoxicosis; no antithyroid drug; repeat TSH and free T4 at 16 to 18 weeks, and test for TSH-receptor antibodies only if it persists or signs of Graves disease appearcompletedGL-ATA-PREG-2017, GL-ACOG-NVP-2018
Monitoring while nausea and vomiting last: PUQE-24, weight, pulse, and blood pressure at every visit; electrolytes until stable on oral intake; liver tests if abnormal; mood each trimester; antiemetic side effects (drowsiness, restlessness or abnormal movements, constipation, palpitations)completedGL-ACOG-NVP-2018, GL-RCOG-HG-2024

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 Project Gutenberg primary
SRC-0002 Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 Project Gutenberg primary
SRC-0003 Charlotte Brontë Wikipedia other
SRC-0004 Brontë family Wikipedia other
SRC-0005 Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 PubMed (PMID 30777294) scholarly
SRC-0006 Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 PubMed (PMID 1923177) scholarly
SRC-0007 Gezari J. The death of Charlotte Brontë OUPblog (Oxford University Press) other
SRC-0008 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the PUQE-based severity grading, the antiemetic steps and ondansetron counseling, thiamine before dextrose, weight-adjusted thromboprophylaxis, the thyroid interpretation, aneuploidy counseling, aspirin, tuberculosis screening, and the recorded deviation.
provenance reviewnot_startedGaskell's Life (both volumes, public domain), two encyclopedia articles, two PubMed abstracts, and a publisher blog essay logged. The final illness, the death certificate, and the reported pregnancy are D; hyperemesis gravidarum, refeeding syndrome, typhoid, tuberculosis with Addison disease, and doubt about the pregnancy are R and conflict. No statement, decision, or health fact is attributed to her husband or father.
safe messaging reviewnot_startedHer death in pregnancy is recorded as a fact without detail. PHQ-9 and EPDS scores are below thresholds with item 9 and item 10 scored 0, so no safety assessment is required.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.